Drug boosts fat tissue's calorie-burning ability in lab

June 17, 2013, The Endocrine Society

A drug that mimics the activity of thyroid hormone significantly increases the amount of energy burned by fat tissue and promotes weight loss, an animal study of metabolism finds. The results were presented Sunday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Humans and other mammals have two kinds of fat, or adipose, tissue, which are referred to by color: white or brown. , or WAT, has low energy-burning capacity. Because of this, WAT is associated with weight gain and obesity, as well as other conditions related to metabolism, which is the process that turns food into energy. These conditions include and blood pressure as well as resistance to the . Combined with excess weight, especially around the torso, these conditions comprise a group of diseases collectively called metabolic syndrome. This syndrome is known to increase the risk of developing heart disease and diabetes.

In contrast, , or BAT, burns energy at a much faster rate, in a process called thermogenesis. Because of this accelerated energy usage, BAT actually helps protect against obesity, rather than contributing to it like WAT does.

With obesity quickly becoming an international epidemic, medical researchers are trying to find ways to increase the body's own fat-burning ability. One approach is to increase the amount of fat that is turned into energy during thermogenesis. New research conducted last year in a genetically engineered animal model showed that the activity of white-fat cells could be altered to behave more like brown-fat cells in terms of their fat-burning capabilities. The changes were small, however, so the potential health benefits of this process, aptly termed "beiging," are unclear.

"BAT has the remarkable ability to dissipate as heat, thus conferring resistance to obesity," said the study's lead author Jean Lin, BS, a graduate research fellow at the Methodist Hospital Research Institute in Houston, TX. "This study has uncovered a new mechanism by which signaling regulates thermogenesis and metabolic rate and demonstrates the profound therapeutic potential of white fat beiging,"

Lin and her co-investigators examined the beiging effects of the experimental drug called GC-1. In the body, this drug binds to proteins called thyroid hormone receptors, which play a role in turning food into energy when activated by thyroid hormone.

They found that GC-1 increased the metabolism of obese mice by more than 60 percent. Furthermore, this increase in metabolic rate led to significant weight loss within two weeks.

"By inducing thermogenesis in white fat, the compound GC-1 gives the remarkable ability to dispose of excess calories by converting them to heat instead of storing them as lipid," Lin said.

The National Institutes of Health funded the study.

Explore further: Team finds mechanism that regulates production of energy-burning brown fat

Related Stories

Team finds mechanism that regulates production of energy-burning brown fat

March 13, 2013
Joslin scientists have discovered a mechanism that regulates the production of brown fat, a type of fat which plays an important role in heat production and energy metabolism. The findings, which appear in the upcoming issue ...

Scientists advance understanding of human brown adipose tissue and grow new cells (w/ Video)

April 22, 2013
Joslin scientists report significant findings about the location, genetic expression and function of human brown adipose tissue (BAT) and the generation of new BAT cells. These findings, which appear in the April 2013 issue ...

Brown adipose tissue beneficial for metabolism and glucose tolerance

December 10, 2012
Joslin Diabetes Center scientists have demonstrated that brown adipose tissue (BAT) has beneficial effects on glucose tolerance, body weight and metabolism. The findings, which may lead to new treatments for diabetes, appear ...

Newly discovered human fat cell opens up new opportunities for future treatment of obesity

May 2, 2013
The body's brown fat cells play a key role in the development of obesity and diabetes. Researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, have now discovered that we humans have two different kinds of brown ...

Scientists find molecular link to obesity and insulin resistance in mice

September 27, 2012
Flipping a newly discovered molecular switch in white fat cells enabled mice to eat a high-calorie diet without becoming obese or developing the inflammation that causes insulin resistance, report scientists from Dana-Farber ...

Scientists identify protein that stimulates brown fat to burn calories

May 10, 2012
Scientists have identified a protein which regulates the activation of brown fat in both the brain and the body's tissues. Their research, which was conducted in mice, was published today, Friday 11 May, in the journal Cell.

Recommended for you

Researchers identify blood biomarkers that may help diagnose, confirm concussions

April 20, 2018
Researchers from the University of California, Irvine, Georgetown University and the University of Rochester have found that specific small molecules in blood plasma may be useful in determining whether someone has sustained ...

DOR protein deficiency favors the development of obesity

April 20, 2018
Obesity is a world health problem. Excessive accumulation of fat tissue (adipose tissue) increases the risk of cardiovascular disease, hypertension, diabetes and some types of cancer. However, some obese individuals are less ...

Stem-cell technology aids 3-D printed cartilage repair

April 20, 2018
Novel stem-cell technology developed at Swinburne will be used to grow the massive number of stem cells required for a new hand-held 3-D printer that will enable surgeons to create patient-specific bone and cartilage.

Enduring cold temperatures alters fat cell epigenetics

April 19, 2018
A new study in fat cells has revealed a molecular mechanism that controls how lifestyle choices and the external environment affect gene expression. This mechanism includes potential targets for next-generation drug discovery ...

Defect in debilitating neurodegenerative disease reversed in mouse nerves

April 19, 2018
Scientists have developed a new drug compound that shows promise as a future treatment for Charcot-Marie-Tooth disease, an inherited, often painful neurodegenerative condition that affects nerves in the hands, arms, feet ...

Molecule that dilates blood vessels hints at new way to treat heart disease

April 19, 2018
Americans die of heart or cardiovascular disease at an alarming rate. In fact, heart attacks, strokes and related diseases will kill an estimated 610,000 Americans this year alone. Some medications help, but to better tackle ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.